Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
EuroIntervention. 2023 Jan 23;18(12):1011-1021. doi: 10.4244/EIJ-D-22-00562.
The integrative implications of quantitative and qualitative plaque characteristics on clinical outcomes and therapeutic guidance have not been fully investigated.
We aimed to investigate the combined prognostic value of quantitative and qualitative plaque measures and their interactions with treatment modalities and physiological lesion severity.
Among 697 vessels from 458 patients who underwent fractional flow reserve (FFR)-guided treatment, quantitative high-risk plaque (qn-HRP; plaque burden ≥70% and minimum lumen area <3.3 mm) and qualitative HRP (ql-HRP; low-attenuation plaque or positive remodelling) were defined on coronary computed tomography angiography (CCTA). The primary endpoint was the vessel-oriented composite outcome (VOCO; a composite of cardiac death, myocardial infarction, or revascularisation).
The mean baseline FFR was 0.85±0.12, and 25.8% underwent percutaneous coronary intervention (PCI) during the index procedure. In medically treated lesions, both qn-HRP and ql-HRP were associated with an increased risk of VOCO (p<0.05). Relative to the lesions with qn-HRP(-)/ql-HRP(-),those with qn-HRP(+)/ql-HRP(+) showed a higher risk of VOCO (hazard ratio [HR] 8.36, 95% confidence interval [CI]: 2.86-24.44). The PCI group showed a lower risk for VOCO than the medical treatment group (HR 0.31, 95% CI: 0.11-0.91) in lesions with qn-HRP(+)/ql-HRP(+). This difference was consistent in lesions with an FFR of 0.81-0.90 (HR 0.19, 95 CI: 0.04-0.90), but not in those with an FFR of>0.90.
In non-ischaemic lesions, ql-HRP and qn-HRP showed a synergistic impact on risk assessment and had prognostic interactions with FFR and treatment modalities. Therefore, they need to be integrated into risk stratification and the optimisation of a treatment strategy.
gov: NCT04037163.
定量和定性斑块特征对临床结果和治疗指导的综合影响尚未得到充分研究。
我们旨在探讨定量和定性斑块指标的联合预后价值及其与治疗方式和生理病变严重程度的相互作用。
在接受血流储备分数(FFR)指导治疗的 458 例患者的 697 支血管中,在冠状动脉计算机断层扫描血管造影(CCTA)上定义了定量高危斑块(qn-HRP;斑块负荷≥70%,最小管腔面积<3.3mm)和定性 HRP(ql-HRP;低衰减斑块或正性重构)。主要终点是血管导向复合结局(VOCO;包括心源性死亡、心肌梗死或血运重建)。
平均基线 FFR 为 0.85±0.12,指数手术期间 25.8%接受经皮冠状动脉介入治疗(PCI)。在药物治疗的病变中,qn-HRP 和 ql-HRP 均与 VOCO 风险增加相关(p<0.05)。与 qn-HRP(-)/ql-HRP(-)的病变相比,qn-HRP(+)/ql-HRP(+)的病变 VOCO 风险更高(危险比[HR]8.36,95%置信区间[CI]:2.86-24.44)。在 qn-HRP(+)/ql-HRP(+)的病变中,与药物治疗组相比,PCI 组 VOCO 风险更低(HR 0.31,95%CI:0.11-0.91)。在 FFR 为 0.81-0.90 的病变中,这种差异是一致的(HR 0.19,95%CI:0.04-0.90),但在 FFR>0.90 的病变中则不然。
在非缺血性病变中,ql-HRP 和 qn-HRP 对风险评估有协同影响,并与 FFR 和治疗方式有预后相互作用。因此,它们需要整合到风险分层和治疗策略的优化中。
gov:NCT04037163。